Asia Pacific Apheresis Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The market is segmented by Product, Indication (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Other Indications), Procedure, and Geography

Home right-chevron-icon Industry Reports right-chevron-icon Healthcare right-chevron-icon Biotechnology right-chevron-icon Asia Pacific Apheresis Market

APAC Apheresis Market Size

Asia Pacific Apheresis Market_1
Study Period: 2018 - 2028
CAGR: 11.26 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and it's growth?

APAC Apheresis Market Analysis

The Asia Pacific apheresis market studied is anticipated to grow with an CAGR of 11.26%, during the forecast period (2019-2024).

The major factors attributing to the growth of the Asia Pacific apheresis market are increasing diseases burden, rise in demand for blood components and associated safety and technological advancement in the development of new apheresis techniques. However, the factors such as high capital investment and cost associated with apheresis procedures is expected to restrain the market.

Apheresis has now become a popular mode of treatment for multiple complex immune disorders and there has been a remarkable change in the scenario pertaining to therapeutic apheresis in Asia-Pacific. With the increasing number of diseases and accident cases, along with technological advancements, the market studied is expected to experience a boost during the forecast period. Additionally, the rising number of government initiatives, blood donation camps, and increasing awareness about healthcare are the factors responsible for the growth of the market studied. Apheresis technology is expensive. It is also technically and medically demanding.

APAC Apheresis Industry Segmentation

Apheresis is a medical technique, where the blood of an individual, either a donor or patient, is passed through an apparatus that separates a particular constituent and returns the rest of the blood to the circulatory system. This is an extracorporeal therapy.

By Product
Devices
Disposables
By Indication
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Other Indications
By Procedure
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukapheresis
Other Procedures
Geography
China
Japan
India
Australia
South Korea
Rest of Asia Pacific

Report scope can be customized per your requirements. Click here.

APAC Apheresis Market Trends

This section covers the major market trends shaping the APAC Apheresis Market according to our research experts:

Neurological Disorders is Expected to Grow with High CAGR in the Indication Segment

The pattern of neurologic diseases in Asia is largely similar to that in the western countries, with cerebrovascular diseases, headache, and epileptic seizures being the most common complaints.

Disease features that are specific to Asia include a high proportion of strokes among the youth, mostly from premature atherosclerosis, a high prevalence of intracranial vs extracranial diseases, the relative commonality of neuromyelitis optica and the optic-spinal form of multiple sclerosis (MS), and high incidences of sex-linked dystonia and Parkinson’s disease. Plasma exchange is one of the well-established therapeutic procedures that is usually used in many neurological autoimmune disorders. It is thought that the effects of plasma exchange occur through the elimination of pathognomonic inflammatory mediators, including autoantibodies, complement components, and cytokines. Most of the neurological disease treatments are benefited with therapeutic apheresis, and these effects most likely occur through the removal of harmful pathogenic autoantibodies and associated inflammatory mediators.

Asia Pacific Apheresis Market_2

APAC Apheresis Industry Overview

The Asia Pacific aphersis market is moderately competitive and consists of several major players. In terms of market share, few major players are currently dominate the apheresis market.  With the increasing prevalence of diseases in the Asia pacific region and the usage of apheresis is expected to rise, thereby few other players are also expected into the market. Some of the major players of the market are Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation and Terumo Corporation are among others.

APAC Apheresis Market Leaders

  1. Asahi Kasei Corporation

  2. B. Braun Melsungen AG

  3. Cerus Corporation

  4. Kaneka Corporation

  5. Terumo Corporation

*Disclaimer: Major Players sorted in no particular order

Asia Pacific Apheresis Market_4

APAC Apheresis Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Disease Burden in Asia

      2. 4.2.2 Rise in Demand for Blood Components and Associated Safety

      3. 4.2.3 Technological Advancement in the Development of New Apheresis Techniques

    3. 4.3 Market Restraints

      1. 4.3.1 High Capital Investment and Cost Associated with Apheresis Procedures

      2. 4.3.2 Risk of Blood Contamination

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Devices

      2. 5.1.2 Disposables

    2. 5.2 By Indication

      1. 5.2.1 Renal Disorders

      2. 5.2.2 Hematological Disorders

      3. 5.2.3 Neurological Disorders

      4. 5.2.4 Autoimmune Disorders

      5. 5.2.5 Other Indications

    3. 5.3 By Procedure

      1. 5.3.1 Plasmapheresis

      2. 5.3.2 Plateletpheresis

      3. 5.3.3 Erythrocytapheresis

      4. 5.3.4 Leukapheresis

      5. 5.3.5 Other Procedures

    4. 5.4 Geography

      1. 5.4.1 China

      2. 5.4.2 Japan

      3. 5.4.3 India

      4. 5.4.4 Australia

      5. 5.4.5 South Korea

      6. 5.4.6 Rest of Asia Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Asahi Kasei Corporation

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Cerus Corporation

      4. 6.1.4 Kaneka Corporation

      5. 6.1.5 Terumo Corporation

      6. 6.1.6 Fresenius SE & Co. KGaA

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

APAC Apheresis Market Research FAQs

The Asia Pacific Apheresis Market is studied from 2018 - 2028.

The Asia Pacific Apheresis Market is valued at 11.26% in 2018.

Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation, Terumo Corporation are the major companies operating in Asia Pacific Apheresis Market.

Asia Pacific Apheresis Industry Report

Statistics for the 2023 Asia Pacific Apheresis market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia Pacific Apheresis analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!